Log In
Print
BCIQ
Print
Print this Print this
 

StarGen

  Manage Alerts
Collapse Summary General Information
Company Oxford BioMedica plc
DescriptionLentiVector-based gene therapy expressing a corrected version of ATP-binding cassette sub-family A member 4 (ABCA4; ABCR)
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Lentivirus
Latest Stage of DevelopmentPhase I/II
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat Stargardt's disease
Regulatory Designation

Partner

Sanofi


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today